# Heart palpitations on a GLP-1: what needs attention

A small average heart-rate increase in trials does not explain every racing or irregular heartbeat. New palpitations need their own assessment.

Canonical: https://velri.co/blog/glp1-heart-palpitations-tradesman-rhythm-signal
Publisher: Velri (https://velri.co/about)
Published: 2026-07-07
Updated: 2026-09-30
Editorial policy: https://velri.co/editorial-policy

A racing, pounding or fluttering heartbeat during GLP-1 treatment deserves its own assessment. Both semaglutide and tirzepatide weight-management labels report small average increases in heart rate. That finding does not identify the cause of an individual's palpitations. [1][2]

Palpitations are a sensation: the heart rhythm can be normal or abnormal when they occur. [3]

## What do the labels report?

In semaglutide injection trials, the average resting-heart-rate increase was one to four beats per minute compared with placebo. Tirzepatide trials reported an average increase of one to three beats per minute, compared with no increase in the placebo group. [1][2]

Those averages do not rule out a more substantial change in an individual. The semaglutide label specifically instructs patients to report palpitations or a racing heartbeat at rest and calls for clinical review of sustained increases. [1]

## What else can contribute?

Caffeine, some medicines, fever and abnormal heart rhythms can cause palpitations. Electrolyte abnormalities can also be relevant. A history and examination help determine whether an electrocardiogram or longer heart monitoring is needed. [3]

Dehydration is another consideration if there has been vomiting, diarrhea or trouble drinking. Rapid heartbeat can accompany severe dehydration, and both medication labels warn about the consequences of fluid loss. [1][2][4]

## When should it be treated as urgent?

Palpitations with chest pain, shortness of breath, loss of consciousness or significant dizziness require emergency medical help. New or different palpitations without those symptoms still warrant prompt contact with a clinician. [3]

For a nonemergency review, useful details include whether the episode starts suddenly, feels regular or irregular, happens at rest or with activity, and how long it lasts. Include caffeine, other medicines, digestive symptoms and any device recording. [3]

A watch can help document the time and observed rate. It does not replace the assessment of the rhythm and associated symptoms. [1][3]

## Sources
[1] DailyMed - WEGOVY- semaglutide injection, solution
WEGOVY- semaglutide tablet (2026). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
[2] DailyMed - ZEPBOUND- tirzepatide injection, solution
ZEPBOUND- tirzepatide injection, solution
ZEPBOUND KWIKPEN- tirzepatide injection, solution (2026). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
[3] Heart palpitations: MedlinePlus Medical Encyclopedia (2026). https://medlineplus.gov/ency/article/003081.htm
[4] Dehydration: MedlinePlus (2024). https://medlineplus.gov/dehydration.html

## About this information
General health information, not personal medical advice, diagnosis or treatment. A prescription is required and is never guaranteed.
Velri is a brand operated by Velri Management LLC, a Nevada limited liability company. Velri is a non-clinical technology and administrative services company. Velri does not provide medical advice, diagnosis, treatment, or pharmacy services, and does not direct the clinical judgment of any provider.
All medical consultations and prescriptions are provided directly by independent provider groups (Online Medical Care, P.C.; TMD of Kansas, P.A.; TMD of Texas, P.A.; and TMD of CA, PC), by a provider licensed in your state. Velri does not employ providers. A prescription is issued only if a provider determines it is clinically appropriate in their independent medical judgment.
All prescription products are dispensed by independent, licensed pharmacies. Velri does not own, operate, or control any pharmacy and does not dispense medication. You may opt out of using a given provider group or pharmacy at any time.
Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state.
Velri is cash-pay. We do not bill Medicare, Medicaid, or commercial insurance. Refunds and order problems are addressed in the Terms of Use; your rights under applicable law are not limited. State availability and clinical eligibility apply.
Velri and telehealth are not for medical emergencies. If you are experiencing an emergency, call 911.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Care is available to eligible adults 18 and older in 47 states and D.C., United States only.
Notice of Privacy Practices: https://velri.co/privacy/notice-of-privacy-practices
Terms: https://velri.co/legal/terms
Provider group or pharmacy opt-out help: https://velri.co/contact and https://velri.co/standards#trust-support